The Muscular Dystrophy Association is the leading funder taking on this disease. We look at its recent research grants—and where the battle against MD now stands after decades of research.
Despite being one of the leading killers of men, claiming nearly 30,000 lives a year, prostate cancer research is seriously underfunded. Two grantmakers are leading the charge, but they can’t do it alone.
It’s not often that we see funders pooling money to create a not-for-profit generic drug company. In fact, we’ve never seen it before. Which is why the creation of Civica Rx deserves a close look.
The Helmsley Charitable Trust continues to address key healthcare challenges faced by rural residents. We look at the latest big grant by this national funder working off the beaten trail on matters of life and death.
The British Heart Foundation hopes to change the future of cardiovascular medicine by offering a research award of nearly $40 million for a groundbreaking idea. It’s one of the largest grants ever offered for biomedical research.
Andrew J. Viterbi's philanthropy tends to be ambitious in terms of size and in scope. We dig into his recent $50 million gift to the University of California, San Diego, which, true to form, aims to cure blindness.
The foundation has pledged $10 million to Stanford Medicine for the training of graduate students in the biomedical sciences, increasing the pipeline of talented young researchers who might otherwise struggle.
We don't see many community foundations prioritize medical research, which is more typically funded by national foundations and major philanthropists. But the Rhode Island Foundation has been working to catalyze and guide donor activity in this space since 2008.
About 60,000 new cases of Parkinson’s disease are diagnosed every year in the U.S. alone. We take a look at what two top research funders are doing to combat this disease.
We're tracking a growing number of donors who've been emerging lately from health and biotech. Cappy Rothman, a pioneer in male reproductive health, is a case in point.
The Wellcome Trust has established a big new fund to back bold ideas that fall outside the realm of conventional life sciences funding. It’s just latest such move by research funders trying to shake things up.
Screen legend John Wayne passed away from cancer in 1979. His family has been working ever since to raise money for cancer research and treatment. We check in with Wayne’s granddaughter on how it’s going.
The Science Philanthropy Alliance released its third survey on private funding for basic science. Overall numbers are steady, and funding continues to be highly concentrated.
It takes extensive training and the right personality to both treat patients and conduct scientific research. There’s been growing concern about the dwindling supply of physicians who do both. This foundation is on the case.
Donors have been reluctant to fund cannabis research on an extensive scale. Recent developments, however, suggest this dynamic may soon change—with major upsides for universities.
A group of heavy hitters, now including the Gates Foundation, are backing a research effort to ensure that global health systems aren’t outflanked by antibiotic-resistant bacteria. The stakes could hardly be higher.
HHMI’s Investigator program—already legendary for its flexible, long-term streams of funding—has now outdone itself, bumping up the period that it supports researchers to seven years. What’s behind this move?
Foundations and research groups increasingly see out-of-the-box collaborations as holding the key to faster medical breakthroughs. Which explains why a top brain funder and heart organization are teaming up.
CZI is playing the long game with its health science funding. Its latest boost to the Human Cell Atlas project seeks to create the framework for global cooperative research for decades to come.
Women of color are disproportionately affected by HIV/AIDS and the harsh practices of the criminal justice system. Now, this group is getting new help around these issues from a top funder in California.
Despite a fast-aging population and growing strains on healthcare entitlements, only a limited number of funders are looking at ways our society can better manage how people die. Still, some money is flowing.
The Aileen Getty Foundation has joined two high-profile grantmakers making waves on the HIV/AIDS funding scene in the Southern states. Who’s winning grants from this new collaboration?
The Open Philanthropy Project is now moving $100 million in grants a year, so it's a big deal that its research funding has finally been getting up to speed after a long gestation. Here's a peek.
The NIH's Accelerating Medicines Partnership, which launched in 2014, is bringing together different sectors in new ways. Now, it's teaming up with the Michael J. Fox Foundation on Parkinson's.
The philanthropic arm of a pharmaceutical company branches out from its usual focus on diseases to look at the social determinants of health with a new gift and funding stream.
The Open Philanthropy Project has been feeling out different approaches for its nascent science program. One interesting RFP sent $11 million to a handful of applicants the NIH had to turn away.
While the days of doctors making house calls are long gone, one couple is trying to bring the practice back for Parkinson’s patients, who can end up homebound and unable to get the treatment they need.
While you might think that a lot of major health funders would be focused on diabetes, that's not really the case. On the upside, some of the foundations that are paying attention have very deep pockets.
Critics worry that a $200 million donation for alternative medicine from a tech billionaire and his wife will tar UC Irvine's Medical School as a haven for quacks. But the gift raises larger questions.
The Breast Cancer Research Foundation is a great example of how funding intermediaries keep gaining momentum, wielding new resources and clout, especially when it comes to medical research.